ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,064.20
0.91%
US Tech 100
17,188.40
0.66%
다우존스 지수
38,225.66
0.85%
Bitcoin
59,350.00
0.39%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Catalyst Pharmaceuticals Inc (CPRX)

  7. Catalyst Pharmaceuticals Inc (CPRX) 뉴스

CPRX Catalyst Pharmaceuticals Inc

15.02
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:01:38
15분 지연
기업명 주식 심볼 시장 주식 타입
Catalyst Pharmaceuticals Inc CPRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 15.02 17:01:38
개장가 저가 고가 종가 전일 종가
15.02
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:00GLOBECatalyst Pharmaceuticals to Participate at the BofA..
22/04/202421:00GLOBECatalyst Pharmaceuticals to Report First Quarter 2024..
28/03/202421:03GLOBECatalyst Pharmaceuticals Announces Support for the Inaugural..
27/03/202421:03GLOBECatalyst Pharmaceuticals to Participate in the 2024 Cantor..
13/03/202420:55GLOBECatalyst Pharmaceuticals Announces AGAMREE® Now Commercially..
05/03/202422:03GLOBECatalyst Pharmaceuticals to Participate at the Barclays 26th..
29/02/202408:03GLOBECatalyst Pharmaceuticals Reports Strong Fourth Quarter and..
27/02/202422:03GLOBECatalyst Pharmaceuticals to Present at MDA Clinical &..
21/02/202423:00GLOBECatalyst Pharmaceuticals Announces Publication of Santhera..
17/02/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202422:03GLOBECatalyst Pharmaceuticals to Report Fourth Quarter and..
10/01/202407:15EDGAR2Form 8-K - Current report
10/01/202406:05GLOBECatalyst Pharmaceuticals, Inc. Announces Closing of Public..
08/01/202422:10EDGAR2Form 8-K - Current report
06/01/202407:23EDGAR2Form 8-K - Current report
06/01/202407:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/01/202422:02GLOBECatalyst Pharmaceuticals, Inc. Announces Pricing of Public..
05/01/202406:49GLOBECatalyst Pharmaceuticals, Inc. Announces Proposed Public..
04/01/202407:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202407:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202407:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202306:30EDGAR2Form 8-K - Current report
18/12/202320:30GLOBECatalyst Pharmaceuticals Announces FIRDAPSE® New Drug..
16/12/202303:47EDGAR2Form 144 - Report of proposed sale of securities
14/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202304:57EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NASDAQ
CPRX
Catalyst Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유